Abstract
Introduction
Antiepileptic drugs (AEDs) are teratogens and confer a risk of congenital malformation. The estimated prevalence of major congenital malformations such as cardiac defects, facial clefts, hypospadias, and neural tube defects in epileptic women is 4–10 %, which represents a two- to fourfold increase in pregnant women compared to the general population. However, there are no clear data for newer drugs. Lacosamide (LCM), a novel AED, is the first of the third-generation AEDs to be approved as adjunctive therapy for the treatment of partial-onset seizures. There are no data on the pharmacokinetics of LCM during pregnancy, and only some published data have reported on its effects during pregnancy.
Methods
In this study, three different doses of LCM (0.12, 0.5, and 1.60 mg in 0.18 mL) were applied under the embryonic disks of specific pathogen-free Leghorn chicken embryos after a 30-h incubation. Incubation was continued for 80 h, at which time all embryos were evaluated macroscopically and microscopically.
Results
There was growth retardation in all of the LCM-treated groups. Major malformations increased in a dose-dependent manner and were mostly observed in the supratherapeutic group.
Conclusion
Based on our data, LCM may cause growth retardation or major congenital malformations. Nevertheless, more extensive investigations of its reliability are needed.
Similar content being viewed by others
References
Patel SI, Pennell PB (2016 Mar) Management of epilepsy during pregnancy: an update. Ther Adv Neurol Disord 9(2):118–129
Gerard EE, Meador KJ (2016 Feb) Managing epilepsy in women. Continuum (Minneap Minn) 22(1 Epilepsy):204–226
Bhakta J, Bainbridge J, Borgelt L (2015) Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy. Epilepsy Behav 52(Pt A):212–217
Hernández-Díaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, Holmes LB, North American AED Pregnancy Registry; North American AED Pregnancy Registry (2012) Comparative safety of antiepileptic drugs during pregnancy. Neurology 22;78(21):1692–1699
Foldvary-Schaefer N, Fong JS, Morrison S, Wang L, Bena J (2016) Lacosamide tolerability in adult patients with partial-onset seizures: impact of planned reduction and mechanism of action of concomitant antiepileptic drugs. Epilepsy Behav 57(Pt A):155–160
Patyar S, Medhi B (2010) Lacosamide, a newer antiepileptic. Neurosciences (Riyadh) 15(1):3–6
. Doty P, Rudd GD, Stoehr T, Thomas D. Lacosamide Neurotherapeutics 2007;4(1):145–148
Ylikotila P, Ketola RA, Timonen S, Malm H, Ruuskanen JO (2015) Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy. Reprod Toxicol 57:204–206
Lee SH, Kang JW, Lin T, Lee JE, Jin DI (2013) Teratogenic potential of antiepileptic drugs in the zebrafish model. Biomed Res Int 2013:726478
Guney O (2003) The effects of folic acid in the prevention of neural tube development defects caused by phenytoin in early chick embryos. Spine 28:442–445
Hamburger V, Hamilton HL (1951) A series of normal stages in the development of the chick embryo. J Morphol 88(1):49–92
Lindhout D, Omtzigt JGC, Cornel MC (1992) Spectrum of neural tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology 42:111–118
Tomson T, Landmark CJ, Battino D (2013) Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications. Epilepsia 54(3):405–414
Sveberg L, Svalheim S, Taubøll E (2015) The impact of seizures on pregnancy and delivery. Seizure 28:35–38
Meador KJ, Loring DW (2016) Developmental effects of antiepileptic drugs and the need for improved regulations. Neurology 19;86(3):297–306
Beyreuther BK, Freitag J, Heers C, Krebsfänger N, Scharfenecker U, Stöhr T (2007) Lacosamide: a review of preclinical properties. CNS Drug Rev 13(1):21–42
Alcantara-Montero A, Sanchez-Carnerero CI (2016) Lacosamide and neuropathic pain, a review. Rev Neurol 1;62(5):223–229
Pitkänen A, Immonen R, Ndode-Ekane X, Gröhn O, Stöhr T, Nissinen J (2014) Effect of lacosamide on structural damage and functional recovery after traumatic brain injury in rats. Epilepsy Res 108(4):653–665
Acknowledgments
The authors would like to thank to Dr. Nayif YILMAZ for his assistance in obtaining the drugs.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All experiments were conducted in accordance with the animal research protocol of Celal Bayar University Ethics Committee (no. 77.637.4335–27).
Conflict of interest
Authors declare that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Mete, M., Gurcu, B., Collu, F. et al. Effects of lacosamide “a novel antiepileptic drug” in the early stages of chicken embryo development. Childs Nerv Syst 32, 1715–1719 (2016). https://doi.org/10.1007/s00381-016-3181-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-016-3181-4